Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Parkson Biotechnology is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of bio-based chemicals and food ingredients. The company is recognized as one of the world's largest manufacturers of gluconic acid derivatives, including sodium gluconate and glucono-delta-lactone (GDL), as well as the natural sweetener erythritol. Its products serve a wide range of industries, including food and beverage, pharmaceuticals, construction, and textiles. Headquartered in Jining, Shandong, the company operates advanced fermentation and purification facilities that adhere to international quality standards. Shandong Parkson Biotechnology maintains a strong global presence, exporting its bio-industrial products to markets across Europe, North America, and Southeast Asia. The firm is a key player in the industrial biotechnology sector, focusing on green chemistry and sustainable manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Parkson Biotechnology.